Literature DB >> 23973109

Third or more repeat hepatectomy for recurrent hepatocellular carcinoma.

Yo-ichi Yamashita1, Ken Shirabe, Eiji Tsuijita, Kazuki Takeishi, Toru Ikegami, Tomoharu Yoshizumi, Yuji Soejima, Tetsuo Ikeda, Tohru Utsunomiya, Yoshihiko Maehara.   

Abstract

BACKGROUND: We sought to evaluate the surgical results of third or more repeat hepatectomy for recurrent hepatocellular carcinoma (HCC). The role of repeat hepatectomy for recurrent HCC, especially in cases with third or more repeat hepatectomy, is controversial.
METHODS: We performed A retrospective, cohort study to analyze the surgical results of repeat hepatectomy performed at a single medical center from 1989 to 2011. A total of 1,000 hepatectomies for HCC were divided into 3 groups: A first hepatectomy group (n = 791), second hepatectomy group (n = 163), and third or more hepatectomy group (n = 46). Operative results and patient prognoses were compared among the 3 groups.
RESULTS: There were no differences in early surgical results such as mortality and morbidity among the 3 groups. The 5-year survival rates after the first, second, and third or more hepatectomy were 67%, 60%, and 43%, respectively (P = .1913). There was a significant difference in disease-free survival among the 3 groups, and the 5-year disease-free survival rates after first, second, and third or more hepatectomy were 37%, 29%, and 18%, respectively (P = .0169).
CONCLUSION: Third or more repeat hepatectomy for recurrent HCC was performed safely and associated with relatively long-term survival. Third or more repeat hepatectomy for recurrent HCC seems justified, but high rate of HCC recurrence remains a problem.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23973109     DOI: 10.1016/j.surg.2013.04.046

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  14 in total

Review 1.  Surgical treatment of intra hepatic recurrence of hepatocellular carcinoma.

Authors:  Laurence Lacaze; Michel Scotté
Journal:  World J Hepatol       Date:  2015-07-08

2.  Liver Resection Versus Embolization for Recurrent Hepatocellular Carcinoma.

Authors:  Yutaka Midorikawa; Tadatoshi Takayama; Masamichi Moriguchi; Rempei Yagi; Shunsuke Yamagishi; Hisashi Nakayama; Osamu Aramaki; Shintaro Yamazaki; Shingo Tsuji; Tokio Higaki
Journal:  World J Surg       Date:  2020-01       Impact factor: 3.352

Review 3.  Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus.

Authors:  Tianfu Wen; Chen Jin; Antonio Facciorusso; Matteo Donadon; Ho-Seong Han; Yilei Mao; Chaoliu Dai; Shuqun Cheng; Bixiang Zhang; Baogang Peng; Shunda Du; Changjun Jia; Feng Xu; Jie Shi; Juxian Sun; Peng Zhu; Satoshi Nara; J Michael Millis
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

4.  Multimodal radiofrequency ablation versus laparoscopic hepatic resection for the treatment of primary hepatocellular carcinoma within Milan criteria in severely cirrhotic patients: long-term favorable outcomes over 10 years.

Authors:  Yo-Ichi Yamashita; Katsunori Imai; Takayoshi Kaida; Takanobu Yamao; Masayo Tsukamoto; Shigeki Nakagawa; Hirohisa Okabe; Akira Chikamoto; Takatoshi Ishiko; Tomoharu Yoshizumi; Tetsuo Ikeda; Yoshihiko Maehara; Hideo Baba
Journal:  Surg Endosc       Date:  2018-06-05       Impact factor: 4.584

5.  The Predictors of Microscopic Vessel Invasion Differ Between Primary Hepatocellular Carcinoma and Hepatocellular Carcinoma with a Treatment History.

Authors:  Yukiyasu Okamura; Teiichi Sugiura; Takaaki Ito; Yusuke Yamamoto; Ryo Ashida; Takeshi Aramaki; Katsuhiko Uesaka
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

Review 6.  Role of hepatectomy for recurrent or initially unresectable hepatocellular carcinoma.

Authors:  Yoji Kishi; Kazuaki Shimada; Satoshi Nara; Minoru Esaki; Tomoo Kosuge
Journal:  World J Hepatol       Date:  2014-12-27

7.  Perioperative Allogeneic Blood Transfusion Does not Influence Patient Survival After Hepatectomy for Hepatocellular Carcinoma: A Propensity Score Matching Analysis.

Authors:  Yo-Ichi Yamashita; Hiromitsu Hayashi; Katsunori Imai; Hirohisa Okabe; Shigeki Nakagawa; Fumimasa Kitamura; Norio Uemura; Yosuke Nakao; Toshihiko Yusa; Rumi Itoyama; Takanobu Yamao; Naoki Umesaki; Tatsunori Miyata; Akira Chikamoto; Mototsugu Shimokawa; Hideo Baba
Journal:  World J Surg       Date:  2019-11       Impact factor: 3.352

8.  Surgery strategy of 13 cases to control bleeding from the liver on laparoscopic repeat liver resection for recurrent hepatocellular carcinoma.

Authors:  Shuiping Yu; Tang Bo; Binzong Hou; Jiangfa Li; Xueling Zhou
Journal:  J Minim Access Surg       Date:  2019 Jul-Sep       Impact factor: 1.407

9.  Surgical management of recurrent intrahepatic cholangiocarcinoma: predictors, adjuvant chemotherapy, and surgical therapy for recurrence: A multi-institutional study by the Kyushu Study Group of Liver Surgery.

Authors:  Yo-Ichi Yamashita; Ken Shirabe; Toru Beppu; Susumu Eguchi; Atsushi Nanashima; Masayuki Ohta; Shinichi Ueno; Kazuhiro Kondo; Kenji Kitahara; Masayuki Shiraishi; Yuko Takami; Tomoaki Noritomi; Kohji Okamoto; Yoshito Ogura; Hideo Baba; Hikaru Fujioka
Journal:  Ann Gastroenterol Surg       Date:  2017-07-20

10.  Microvascular invasion of single small hepatocellular carcinoma ≤3 cm: Predictors and optimal treatments.

Authors:  Yo-Ichi Yamashita; Katsunori Imai; Toshihiko Yusa; Yosuke Nakao; Yuki Kitano; Shigeki Nakagawa; Hirohisa Okabe; Akira Chikamoto; Takatoshi Ishiko; Tomoharu Yoshizumi; Shinichi Aishima; Yoshihiko Maehara; Hideo Baba
Journal:  Ann Gastroenterol Surg       Date:  2018-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.